AKT1 and hepatocellular carcinoma: indicated that lncRNA PDPK2P can interact with 1,3-phosphoinositide‐dependent protein kinase-1 (PDK1) and regulate the development of hepatocellular carcinoma through PDK1/AKT/caspase-3 signaling pathway (38).